These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

274 related items for PubMed ID: 27216760

  • 1. Risk of solid organ transplant rejection following vaccination with seasonal trivalent inactivated influenza vaccines in England: A self-controlled case-series.
    Dos Santos G, Haguinet F, Cohet C, Webb D, Logie J, Ferreira GL, Rosillon D, Shinde V.
    Vaccine; 2016 Jun 30; 34(31):3598-606. PubMed ID: 27216760
    [Abstract] [Full Text] [Related]

  • 2. Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case series.
    Cohet C, Haguinet F, Dos Santos G, Webb D, Logie J, Lc Ferreira G, Rosillon D, Shinde V.
    BMJ Open; 2016 Jan 28; 6(1):e009264. PubMed ID: 26823177
    [Abstract] [Full Text] [Related]

  • 3. Panel Reactive Antibody Responses Against Influenza Vaccination in Kidney Transplant Recipients.
    Khishigsuren B, Demir E, Akgul SU, Temurhan S, Ucar AR, Dirim AB, Catikkas NM, Bayraktar A, Caliskan Y, Yazici H, Oguz FS, Turkmen A, Sever MS.
    Transplant Proc; 2019 May 28; 51(4):1115-1117. PubMed ID: 31101183
    [Abstract] [Full Text] [Related]

  • 4. Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013-2014 and 2014-2015 seasons.
    Li R, Stewart B, McNeil MM, Duffy J, Nelson J, Kawai AT, Baxter R, Belongia EA, Weintraub E.
    Pharmacoepidemiol Drug Saf; 2016 Aug 28; 25(8):928-34. PubMed ID: 27037540
    [Abstract] [Full Text] [Related]

  • 5. Influenza vaccination coverage among adult solid organ transplant recipients at three health maintenance organizations, 1995-2005.
    Harris K, Baggs J, Davis RL, Black S, Jackson LA, Mullooly JP, Chapman LE.
    Vaccine; 2009 Apr 14; 27(17):2335-41. PubMed ID: 19428848
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial.
    Mombelli M, Rettby N, Perreau M, Pascual M, Pantaleo G, Manuel O.
    Vaccine; 2018 Oct 01; 36(41):6163-6169. PubMed ID: 30181045
    [Abstract] [Full Text] [Related]

  • 7. Randomized, double-blind comparison of standard-dose vs. high-dose trivalent inactivated influenza vaccine in pediatric solid organ transplant patients.
    GiaQuinta S, Michaels MG, McCullers JA, Wang L, Fonnesbeck C, O'Shea A, Green M, Halasa NB.
    Pediatr Transplant; 2015 Mar 01; 19(2):219-28. PubMed ID: 25523718
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Influenza vaccination and humoral alloimmunity in solid organ transplant recipients.
    Vermeiren P, Aubert V, Sugamele R, Aubert JD, Venetz JP, Meylan P, Pascual M, Manuel O.
    Transpl Int; 2014 Sep 01; 27(9):903-8. PubMed ID: 24797932
    [Abstract] [Full Text] [Related]

  • 10. Antibody persistence 1 year after pandemic H1N1 2009 influenza vaccination and immunogenicity of subsequent seasonal influenza vaccine among adult organ transplant patients.
    Felldin M, Andersson B, Studahl M, Svennerholm B, Friman V.
    Transpl Int; 2014 Feb 01; 27(2):197-203. PubMed ID: 24289658
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness and safety of inactivated influenza vaccination in pediatric liver transplant recipients over three influenza seasons.
    Gotoh K, Ito Y, Suzuki E, Kaneko K, Kiuchi T, Ando H, Kimura H.
    Pediatr Transplant; 2011 Feb 01; 15(1):112-6. PubMed ID: 21108713
    [Abstract] [Full Text] [Related]

  • 12. Impact of Pharmacy-Initiated Interventions on Influenza Vaccination Rates in Pediatric Solid Organ Transplant Recipients.
    Gattis S, Yildirim I, Shane AL, Serluco S, McCracken C, Liverman R.
    J Pediatric Infect Dis Soc; 2019 Dec 27; 8(6):525-530. PubMed ID: 30307524
    [Abstract] [Full Text] [Related]

  • 13. Immunogenicity of inactivated seasonal influenza vaccine in adult and pediatric liver transplant recipients over two seasons.
    Suzuki M, Torii Y, Kawada J, Kimura H, Kamei H, Onishi Y, Kaneko K, Ando H, Kiuchi T, Ito Y.
    Microbiol Immunol; 2013 Oct 27; 57(10):715-22. PubMed ID: 23909408
    [Abstract] [Full Text] [Related]

  • 14. Impact of squalene-based adjuvanted influenza vaccination on graft outcome in kidney transplant recipients.
    Fernández-Ruiz M, Lumbreras C, Arrazola MP, López-Medrano F, Andrés A, Morales JM, de Juanes JR, Aguado JM.
    Transpl Infect Dis; 2015 Apr 27; 17(2):314-21. PubMed ID: 25728936
    [Abstract] [Full Text] [Related]

  • 15. Effect of two injections of non-adjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial.
    Le Corre N, Thibault F, Pouteil Noble C, Meiffrédy V, Daoud S, Cahen R, Charreau I, Bottigioli D, Dollinger C, Aboulker JP, Autran B, Morelon E, Barrou B.
    Vaccine; 2012 Dec 14; 30(52):7522-8. PubMed ID: 23103195
    [Abstract] [Full Text] [Related]

  • 16. Influenza vaccination during the first 6 months after solid organ transplantation is efficacious and safe.
    Pérez-Romero P, Bulnes-Ramos A, Torre-Cisneros J, Gavaldá J, Aydillo TA, Moreno A, Montejo M, Fariñas MC, Carratalá J, Muñoz P, Blanes M, Fortún J, Suárez-Benjumea A, López-Medrano F, Barranco JL, Peghin M, Roca C, Lara R, Cordero E, Influenza Vaccine in Solid Organ Transplant Recipient Study Group, Spanish Network of Research in Infectious Diseases (REIPI-GESITRA), Influenza Vaccine in Solid Organ Transplant Recipient Study Group Spanish Network of Research in Infectious Diseases REIPI-GESITRA.
    Clin Microbiol Infect; 2015 Nov 14; 21(11):1040.e11-8. PubMed ID: 26232537
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of a booster dose of influenza vaccination in solid organ transplant recipients, TRANSGRIPE 1-2: study protocol for a multicenter, randomized, controlled clinical trial.
    Martinez-Atienza J, Rosso-Fernández C, Roca C, Aydillo TA, Gavaldà J, Moreno A, Montejo JM, Torre-Cisneros J, Fariñas MC, Fortun J, Sabé N, Muñoz P, Blanes-Julia M, Suárez-Benjumea A, López-Medrano F, Pérez-Romero P, Cordero E, TRANSGRIPE 1-2 Study Group.
    Trials; 2014 Aug 28; 15():338. PubMed ID: 25168918
    [Abstract] [Full Text] [Related]

  • 18. Observational safety study of specific outcomes after trivalent cell culture seasonal influenza vaccination (Optaflu® ) among adults in THIN database of electronic UK primary healthcare records.
    Hall GC, Davies PTG, Karim MY, Haag MDM, O'Leary C.
    Pharmacoepidemiol Drug Saf; 2018 Jan 28; 27(1):52-58. PubMed ID: 29152808
    [Abstract] [Full Text] [Related]

  • 19. No effect of 2008/09 seasonal influenza vaccination on the risk of pandemic H1N1 2009 influenza infection in England.
    Pebody R, Andrews N, Waight P, Malkani R, McCartney C, Ellis J, Miller E.
    Vaccine; 2011 Mar 21; 29(14):2613-8. PubMed ID: 21292008
    [Abstract] [Full Text] [Related]

  • 20. Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan.
    Saito N, Komori K, Suzuki M, Morimoto K, Kishikawa T, Yasaka T, Ariyoshi K.
    Vaccine; 2017 Jan 23; 35(4):687-693. PubMed ID: 28043738
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.